Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High affinity phenylglycinol-based NK1 receptor antagonists

A P Owens1, T Harrison, J D Moseley

  • 1Department of Medicinal Chemistry, Merck Sharp and Dohme Research Laboratories, Harlow, Essex, U.K. andrew_owens@merck.com

Bioorganic & Medicinal Chemistry Letters
|January 1, 1999
PubMed
Summary

Researchers explored heterocyclic replacements for a key group in human NK1 (neurokinin 1) receptor antagonists. This led to the development of acyclic compounds demonstrating very high affinity for the hNK1 receptor.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A unified and multi-scale Source: Pathway Priority Index for diffuse pollution management.

Water research·2025
Same author

Observation of Exotic J/ψϕ Resonant Structure in Diffractive Processes in Proton-Proton Collisions.

Physical review letters·2025
Same author

Observation of New Charmonium or Charmoniumlike States in B^{+}→D^{*±}D^{∓}K^{+} Decays.

Physical review letters·2024
Same author

Modification of χ_{c1}(3872) and ψ(2S) Production in pPb Collisions at sqrt[s_{NN}]=8.16  TeV.

Physical review letters·2024
Same author

Amplitude Analysis of the B^{0}→K^{*0}μ^{+}μ^{-} Decay.

Physical review letters·2024
Same author

Fraction of χ_{c} Decays in Prompt J/ψ Production Measured in pPb Collisions at sqrt[s_{NN}]=8.16  TeV.

Physical review letters·2024

Area of Science:

  • Medicinal Chemistry
  • Neuroscience
  • Pharmacology

Background:

  • The neurokinin 1 (NK1) receptor is a validated target for various therapeutic applications.
  • Previous research focused on phenylglycinol-based antagonists for the human NK1 (hNK1) receptor.

Purpose of the Study:

  • To investigate novel heterocyclic replacements for the carboxamido group in phenylglycinol-based hNK1 receptor antagonists.
  • To develop novel acyclic compounds with improved affinity for the hNK1 receptor.

Main Methods:

  • Synthesis of novel heterocyclic compounds.
  • Evaluation of binding affinity for the hNK1 receptor.

Main Results:

  • Successful identification of heterocyclic replacements for the carboxamido moiety.

Related Experiment Videos

  • Development of acyclic compounds exhibiting sub-nanomolar affinity for the hNK1 receptor.

    • Conclusions:

    • Heterocyclic modifications represent a viable strategy for developing potent hNK1 receptor antagonists.
    • The identified acyclic compounds show significant potential for further therapeutic development targeting the hNK1 receptor.